Dompé
NICE rejects Akcea’s rare inherited disorder drug Waylivra
Draft guidance deems drug too costly for NHS use
Germany will be first EU launch market for new Soliris indication
Alexion 'currently evaluating' additional European launches for its orphan drug
European Commission approves Dompé’s orphan drug
Oxervate will treat patients with neurotrophic keratitis
AstraZeneca gains FDA orphan status for new cancer drug
Gains a longer patent life for the investigational lung disease drug